Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.

Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...

Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of ...

Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.

CoreWeave’s acquisition of Core Scientific is facing shareholder pushback, sparking a rally in AI tokens and centralization questions.